139 related articles for article (PubMed ID: 34927243)
21. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma.
Feng J; Li J; Wu L; Yu Q; Ji J; Wu J; Dai W; Guo C
J Exp Clin Cancer Res; 2020 Jul; 39(1):126. PubMed ID: 32631382
[TBL] [Abstract][Full Text] [Related]
22. Myeloid differentiation factor 88 promotes growth and metastasis of human hepatocellular carcinoma.
Liang B; Chen R; Wang T; Cao L; Liu Y; Yin F; Zhu M; Fan X; Liang Y; Zhang L; Guo Y; Zhao J
Clin Cancer Res; 2013 Jun; 19(11):2905-16. PubMed ID: 23549880
[TBL] [Abstract][Full Text] [Related]
23. Circular RNA MAT2B Promotes Glycolysis and Malignancy of Hepatocellular Carcinoma Through the miR-338-3p/PKM2 Axis Under Hypoxic Stress.
Li Q; Pan X; Zhu D; Deng Z; Jiang R; Wang X
Hepatology; 2019 Oct; 70(4):1298-1316. PubMed ID: 31004447
[TBL] [Abstract][Full Text] [Related]
24. Hepatic stellate cells activated by acidic tumor microenvironment promote the metastasis of hepatocellular carcinoma via osteopontin.
Song J; Ge Z; Yang X; Luo Q; Wang C; You H; Ge T; Deng Y; Lin H; Cui Y; Chu W; Yao M; Zhang Z; Gu J; Fan J; Qin W
Cancer Lett; 2015 Jan; 356(2 Pt B):713-20. PubMed ID: 25449435
[TBL] [Abstract][Full Text] [Related]
25. Inhibiting aerobic glycolysis suppresses renal interstitial fibroblast activation and renal fibrosis.
Ding H; Jiang L; Xu J; Bai F; Zhou Y; Yuan Q; Luo J; Zen K; Yang J
Am J Physiol Renal Physiol; 2017 Sep; 313(3):F561-F575. PubMed ID: 28228400
[TBL] [Abstract][Full Text] [Related]
26. MyD88 in Macrophages Enhances Liver Fibrosis by Activation of NLRP3 Inflammasome in HSCs.
Ge S; Yang W; Chen H; Yuan Q; Liu S; Zhao Y; Zhang J
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830293
[TBL] [Abstract][Full Text] [Related]
27. Inducible factors for cancer-associated fibroblasts in liver cancer versus myofibroblasts in inflammatory liver disease.
Okabe H; Hayashi H; Nakagawa S; Imai K; Nitta H; Arima K; Hashimoto D; Chikamoto A; Ishiko T; Beppu T; Baba H
Histol Histopathol; 2016 Feb; 31(2):141-8. PubMed ID: 26398776
[TBL] [Abstract][Full Text] [Related]
28. Activation of tumor-promoting pathways implicated in hepatocellular adenoma/carcinoma, a long-term complication of glycogen storage disease type Ia.
Cho JH; Lee YM; Bae SH; Chou JY
Biochem Biophys Res Commun; 2020 Jan; 522(1):1-7. PubMed ID: 31735334
[TBL] [Abstract][Full Text] [Related]
29. The contribution of toll-like receptor signaling to the development of liver fibrosis and cancer in hepatocyte-specific TAK1-deleted mice.
Song IJ; Yang YM; Inokuchi-Shimizu S; Roh YS; Yang L; Seki E
Int J Cancer; 2018 Jan; 142(1):81-91. PubMed ID: 28875549
[TBL] [Abstract][Full Text] [Related]
30. Pyruvate kinase M2 affects liver cancer cell behavior through up-regulation of HIF-1α and Bcl-xL in culture.
Dong T; Yan Y; Chai H; Chen S; Xiong X; Sun D; Yu Y; Deng L; Cheng F
Biomed Pharmacother; 2015 Feb; 69():277-84. PubMed ID: 25661370
[TBL] [Abstract][Full Text] [Related]
31. Transforming growth factor beta-1 upregulates glucose transporter 1 and glycolysis through canonical and noncanonical pathways in hepatic stellate cells.
Zhou MY; Cheng ML; Huang T; Hu RH; Zou GL; Li H; Zhang BF; Zhu JJ; Liu YM; Liu Y; Zhao XK
World J Gastroenterol; 2021 Oct; 27(40):6908-6926. PubMed ID: 34790014
[TBL] [Abstract][Full Text] [Related]
32. Paracrine Hedgehog signaling drives metabolic changes in hepatocellular carcinoma.
Chan IS; Guy CD; Chen Y; Lu J; Swiderska-Syn M; Michelotti GA; Karaca G; Xie G; Krüger L; Syn WK; Anderson BR; Pereira TA; Choi SS; Baldwin AS; Diehl AM
Cancer Res; 2012 Dec; 72(24):6344-50. PubMed ID: 23066040
[TBL] [Abstract][Full Text] [Related]
33. Exosomes from activated hepatic stellate cells contain GLUT1 and PKM2: a role for exosomes in metabolic switch of liver nonparenchymal cells.
Wan L; Xia T; Du Y; Liu J; Xie Y; Zhang Y; Guan F; Wu J; Wang X; Shi C
FASEB J; 2019 Jul; 33(7):8530-8542. PubMed ID: 30970216
[TBL] [Abstract][Full Text] [Related]
34. Metformin delays AKT/c-Met-driven hepatocarcinogenesis by regulating signaling pathways for de novo lipogenesis and ATP generation.
Zhang C; Hu J; Sheng L; Yuan M; Wu Y; Chen L; Zheng G; Qiu Z
Toxicol Appl Pharmacol; 2019 Feb; 365():51-60. PubMed ID: 30625338
[TBL] [Abstract][Full Text] [Related]
35. Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth.
Sun Q; Chen X; Ma J; Peng H; Wang F; Zha X; Wang Y; Jing Y; Yang H; Chen R; Chang L; Zhang Y; Goto J; Onda H; Chen T; Wang MR; Lu Y; You H; Kwiatkowski D; Zhang H
Proc Natl Acad Sci U S A; 2011 Mar; 108(10):4129-34. PubMed ID: 21325052
[TBL] [Abstract][Full Text] [Related]
36. Hedgehog signaling antagonist promotes regression of both liver fibrosis and hepatocellular carcinoma in a murine model of primary liver cancer.
Philips GM; Chan IS; Swiderska M; Schroder VT; Guy C; Karaca GF; Moylan C; Venkatraman T; Feuerlein S; Syn WK; Jung Y; Witek RP; Choi S; Michelotti GA; Rangwala F; Merkle E; Lascola C; Diehl AM
PLoS One; 2011; 6(9):e23943. PubMed ID: 21912653
[TBL] [Abstract][Full Text] [Related]
37. p,p'-Dichlorodiphenyltrichloroethane promotes aerobic glycolysis via reactive oxygen species-mediated extracellular signal-regulated kinase/M2 isoform of pyruvate kinase (PKM2) signaling in colorectal cancer cells.
Song L; Dong N; Li Z
Environ Toxicol; 2020 Mar; 35(3):333-345. PubMed ID: 31724279
[TBL] [Abstract][Full Text] [Related]
38. Signal transducer and activator of transcription 3 promotes the Warburg effect possibly by inducing pyruvate kinase M2 phosphorylation in liver precancerous lesions.
Bi YH; Han WQ; Li RF; Wang YJ; Du ZS; Wang XJ; Jiang Y
World J Gastroenterol; 2019 Apr; 25(16):1936-1949. PubMed ID: 31086462
[TBL] [Abstract][Full Text] [Related]
39. Myofibroblast-Specific Msi2 Knockout Inhibits HCC Progression in a Mouse Model.
Qu C; He L; Yao N; Li J; Jiang Y; Li B; Peng S; Hu K; Chen D; Chen G; Huang W; Cao M; Fan J; Yuan Y; Ye W; Hong J
Hepatology; 2021 Jul; 74(1):458-473. PubMed ID: 33609283
[TBL] [Abstract][Full Text] [Related]
40. Focal adhesion kinase-related non-kinase ameliorates liver fibrosis by inhibiting aerobic glycolysis
Huang T; Li YQ; Zhou MY; Hu RH; Zou GL; Li JC; Feng S; Liu YM; Xin CQ; Zhao XK
World J Gastroenterol; 2022 Jan; 28(1):123-139. PubMed ID: 35125823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]